Asahi Kasei Medical has launched BioOptimal MF-SL, its new range of microfilters for bioprocessing applications. BioOptimal MF-SL filters, designed for use in cell culture clarification applications, enable biopharmaceutical manufacturers to improve the efficiency and effectiveness of their protein harvest step.
Asahi Kasei claimed that the BioOptimal MF-SL filters, developed using Asahi Kasei’s technology base in hollow-fiber filtration and polymer science, offer superior filtration performance that results in faster processing times and higher-quality protein streams, even when filtering high-density cell culture solutions.
The hollow-fiber membrane structure used in BioOptimal MF-SL filters enables gentle processing of cells and proteins in tangential flow mode, which reduces the burden on subsequent processing steps, and additionally makes the filters suitable for use in perfusion-based fermentation processes.
The key features of BioOptimal MF-SL include high throughput and fast processing times, enhanced filter performance even with high-density cell culture, high clarity of filtrate, even with highly turbid cell culture, availability of various surface area sizes, making for easy scalability, chemically stable polysulfone membrane, compatible with industry standard cleaning and sterilization processes.
Asahi Kasei Medical is developing its range of advanced manufacturing solutions for the bioprocess industry. In addition, equipment solutions for bioprocessing like chromatography equipment, in-line buffer dilution systems, and virus filtration and integrity test skids are also available from the company’s wholly owned US subsidiary Asahi Kasei Bioprocess.